Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Co-administration of Metformin and Daclatasvir
NCT03686722Phase 1Completed
- Start
- Sep 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of daclatasvir in hepatitis C (HCV) (2 arms). Primary endpoints: Area under the Plasma concentration Versus Time Curve from time 0 to 12 hours, Area under the plasma concentration-time curve from time 0 to infinity and 8 more. Started Sep 2017; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03686722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686722.